Literature DB >> 15868934

Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells.

Hong Z Lee1, Henry Wing C Leung, Miao Y Lai, Chun H Wu.   

Abstract

Baicalein, a flavonoid compound, is one of the active constituents of the root of Scutellariae Radix. Baicalein inhibited the growth of human lung squamous carcinoma CH27 cells in a dose-dependent manner. Cell cycle analysis revealed an increase in the S-phase cell population following 24-h exposure to 50 microM baicalein. During the S-phase arrest, analysis of cell cycle regulatory molecules demonstrated that baicalein decreased the levels of cdk 4, cyclin B1 and cyclin D1. Furthermore, baicalein (50 microM) significantly induced cell apoptosis after 3 days of treatment. Baicalein induced apoptosis, as confirmed by condensed nuclei and DNA fragmentation, in CH27 cells. Baicalein-induced apoptosis was also accompanied by a decrease in Bcl-2 and caspase-3 proform levels. These results suggest that baicalein inhibits the proliferation of CH27 cells via S-phase arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868934

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  32 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

2.  Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract.

Authors:  Zong-Fang Li; Zhi-Dong Wang; Yuan-Yuan Ji; Shu Zhang; Chen Huang; Jun Li; Xian-Ming Xia
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

3.  Anticancer properties of baicalein: a review.

Authors:  Ying Gao; Shane A Snyder; Jaclyn N Smith; Yi Charlie Chen
Journal:  Med Chem Res       Date:  2016-06-29       Impact factor: 1.965

4.  Expression of prostate stem cell antigen is downregulated during flavonoid-induced cytotoxicity in prostate cancer cells.

Authors:  Qiang Zhang; Guangdong Cheng; Hongbin Qiu; Yuexin Wang; Jingtao Wang; Hui Xu; Tao Zhang; Lixin Liu; Ye Tao; Zhongjuan Ren
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

5.  Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.

Authors:  Chieh-Yu Peng; Shiow-Lin Pan; Ying-Wen Huang; Jih-Hwa Guh; Ya-Ling Chang; Che-Ming Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

6.  Baicalein inhibits DMBA/TPA-induced skin tumorigenesis in mice by modulating proliferation, apoptosis, and inflammation.

Authors:  Guo-Zhang Ma; Chun-Hui Liu; Bin Wei; Jie Qiao; Tao Lu; Hua-Chen Wei; Hong-Duo Chen; Chun-Di He
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

7.  12-lipoxygenase induces apoptosis of human gastric cancer AGS cells via the ERK1/2 signal pathway.

Authors:  Feng-Lin Chen; Xiao-Zhong Wang; Jian-Ying Li; Jie-Ping Yu; Cai-Yun Huang; Zhi-Xin Chen
Journal:  Dig Dis Sci       Date:  2007-05-24       Impact factor: 3.199

8.  An in vitro based investigation of the cytotoxic effect of water extracts of the Chinese herbal remedy LD on cancer cells.

Authors:  Shaun Willimott; James Barker; Lucy A Jones; Elizabeth I Opara
Journal:  Chem Cent J       Date:  2009-09-28       Impact factor: 4.215

9.  Anti-Bladder-Tumor Effect of Baicalein from Scutellaria baicalensis Georgi and Its Application In Vivo.

Authors:  Jin-Yi Wu; Kun-Wei Tsai; Yi-Zhen Li; Yi-Sheng Chang; Yi-Chien Lai; Yu-Han Laio; Jiann-Der Wu; Yi-Wen Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-17       Impact factor: 2.629

10.  Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway.

Authors:  Hong-Bo Zhang; Ping Lu; Qing-Yin Guo; Zhen-Hua Zhang; Xiang-Yu Meng
Journal:  Oncol Lett       Date:  2012-12-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.